<DOC>
	<DOCNO>NCT02390154</DOCNO>
	<brief_summary>The purpose trial investigate fate roniciclib ( study drug ) body call mass-balance study . This mean investigate study drug absorb , distribute , broken ( metabolize ) remove ( excrete eliminate ) body .</brief_summary>
	<brief_title>Roniciclib Mass Balance Study</brief_title>
	<detailed_description />
	<criteria>Male female subject age â‰¥18 year Eastern Cooperative Oncology Group ( ECOG ) performance status 0 2 Subjects advance , histologically cytologically confirm solid tumor , refractory standard therapy , standard therapy available , subject must actively refuse treatment would regard standard , / judgment investigator , experimental treatment clinically ethically acceptable Adequate bone marrow , liver , renal function assess laboratory requirement conduct within 14 day prior first dose study drug : Previous deep vein thrombosis ( within last 6 month ) , arterial thrombotic event ( include stroke ) , pulmonary embolism History cardiac disease : congestive heart failure New York Heart Association ( NYHA ) class III IV , angina ( within past 6 month prior study entry ) , myocardial infarction , cardiac arrhythmia require antiarrhythmic therapy ( beta blocker digoxin permit ) Anticancer chemotherapy immunotherapy within 4 week study entry . Mitomycin C nitrosoureas give within 6 week study entry . Accepted exemption bisphosphonates , luteinising hormone release hormone ( LHRH ) agonists prostate cancer , mitotane adrenal carcinoma . Radiotherapy within 3 week prior first dose study drug . Palliative radiotherapy allow Intake strong CYP3A4 inhibitor ( e.g. , boceprevir , clarithromycin , conivaptan , indinavir , itraconazole , ketoconazole , lopinavir/ritonavir , mibefradil ( withdrawn US ) , nefazodone , nelfinavir , posaconazole , ritonavir , saquinavir , telaprevir , telithromycin voriconazole ) strong CYP3A4 inducer ( e.g. , carbamazepine , phenytoin , rifampin St. John 's Wort )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>